강박 장애(OCD) 시장 규모, 점유율 및 성장 분석 : 치료법별, 중증도별, 유통경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Obsessive Compulsive Disorder Market size was valued at USD 3.52 Billion in 2024 and is poised to grow from USD 3.75 Billion in 2025 to USD 6.22 Billion by 2033, growing at a CAGR of 6.52% during the forecast period (2026-2033).

The global market for Obsessive-Compulsive Disorder (OCD) is propelled by the increasing prevalence of the condition, enhanced diagnostic criteria, and heightened awareness. As more cases are identified and treated, particularly through the adoption of DSM-5 guidelines, the expanding patient pool is significant, with the economic impact estimated at $8-10 billion globally due to healthcare costs and lost productivity. While the market has traditionally relied on selective serotonin reuptake inhibitors and cognitive-behavioral therapy, recent advancements include novel treatments and digital therapeutics. The introduction of FDA-cleared apps enhances accessibility to care, prompting insurers to cover these solutions, which fosters provider adoption. Collaboration between pharmaceutical and tech companies is driving innovations that integrate AI for symptom monitoring, creating new revenue opportunities and improving service delivery in underserved areas.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Obsessive Compulsive Disorder market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Obsessive Compulsive Disorder Market Segments Analysis

Global obsessive compulsive disorder market is segmented by treatment, severity, distribution, end-user and region. Based on treatment, the market is segmented into SSRIs (Fluvoxamine, Sertraline), Clomipramine (TCA), CBT/ERP Therapy and Deep Brain Stimulation. Based on severity, the market is segmented into Mild-Moderate and Severe/Treatment-Resistant. Based on distribution, the market is segmented into Retail Pharmacies and Hospital Pharmacies. Based on end-user, the market is segmented into Psychiatry Clinics, Hospitals and Telehealth. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Obsessive Compulsive Disorder Market

The Global Obsessive Compulsive Disorder market is significantly influenced by a rise in awareness, leading to more individuals pursuing professional evaluations, which in turn aids in the prompt recognition of symptoms and facilitates timely intervention. This proactive approach minimizes the duration of untreated conditions, enhances treatment outcomes, and fosters an openness towards various therapeutic options among both patients and their caregivers. Consequently, there is an increased demand for diagnostic services, pharmacological interventions, and supportive care, contributing to robust market growth through elevated service usage and wider acceptance of mental health initiatives. Additionally, initiatives from media campaigns and patient advocacy organizations further enhance understanding, promoting early clinical assessments and long-term adherence to treatment plans.

Restraints in the Global Obsessive Compulsive Disorder Market

The global market for Obsessive Compulsive Disorder (OCD) therapies faces challenges due to insufficient insurance coverage and restrictive reimbursement policies, which hinder patient access and affordability. Many individuals are compelled to delay or avoid treatment altogether because payers often focus on immediate cost reductions rather than investing in comprehensive mental health care. This prioritization leads to limitations in the availability of therapies and restricted session allocations, discouraging healthcare providers from endorsing innovative treatment options that may lack adequate reimbursement support. As a result, the adoption of advanced pharmacological and behavioral therapies is sluggish, and the absence of standardized coverage guidelines heightens uncertainty for both patients and providers, further stalling market growth.

Market Trends of the Global Obsessive Compulsive Disorder Market

The Global Obsessive Compulsive Disorder market is witnessing a significant shift towards digital therapeutics, with innovative platforms offering cognitive-behavioral therapy and exposure response prevention gaining widespread acceptance. Clinicians and patients are increasingly leveraging mobile applications for real-time symptom monitoring and tailored interventions, minimizing the need for traditional in-person consultations. Health systems are recognizing these digital solutions as cost-effective alternatives that enhance treatment adherence and patient outcomes. The clarity in regulatory pathways is fueling substantial investments from startups and established pharmaceutical companies in evidence-based digital tools, thereby accelerating market penetration and opening new revenue streams across the global OCD treatment landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Obsessive Compulsive Disorder Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• SSRIs (Fluvoxamine, Sertraline)
• Clomipramine (TCA)
• CBT/ERP Therapy
• Deep Brain Stimulation

Global Obsessive Compulsive Disorder Market Size by Severity & CAGR (2026-2033)

• Market Overview
• Mild-Moderate
• Severe/Treatment-Resistant

Global Obsessive Compulsive Disorder Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies

Global Obsessive Compulsive Disorder Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Psychiatry Clinics
• Hospitals
• Telehealth

Global Obsessive Compulsive Disorder Market Size & CAGR (2026-2033)

• North America (Treatment, Severity, Distribution, End-User)
  • US
  • Canada
• Europe (Treatment, Severity, Distribution, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment, Severity, Distribution, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment, Severity, Distribution, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment, Severity, Distribution, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (Zoloft/Sertraline)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohaven Pharmaceutical (Troriluzole)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (DBS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (DBS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen (J&J)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lundbeck
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alto Neuroscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMPASS Pathways
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurocrine Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axsome Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Noven Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InVivo Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations